Johns Hopkins University, Yale University, and New York University are teaming up to develop a curriculum for psychiatrists on psychedelics, with a $1 million grant funding the project over 2 years.
Johns Hopkins University
English
Two years
Johns Hopkins University, Yale University, and New York University have announced they are collaborating to create a psychedelics curriculum for psychiatrists. A $1 million grant will fund researchers at the three schools over the next two years to develop a curriculum for psychiatrists and create educational materials for other medical professionals.
The program aims to adequately train medical professionals in psychedelic therapy to increase patient access to these therapies. Pending approval from the Accreditation Council for Graduate Medical Education, psychiatrists can specialize in psychedelic psychiatry, like child psychiatry or forensic psychiatry. Funding has come from philanthropic donations from The Heffter Research Institute, Tim Ferriss, Bill Linton, Michael and Lisa Cotton, and the Evolve Foundation.
Also, see this more recent article from Yale.
Psychiatrists and other medical professionals
The Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.
Next cohort: May 20, 2026